Abstract
Hybrid molecules have been developed which are comprised of a tyrosine kinase-targeted, quinazoline-based scaffold and a flexibly linked dia(m)minechloridoPt(ii) moiety. The target compounds maintain high affinity and selectivity for ErbB family kinase proteins and one of the derivatives induces platinum adducts with a pharmacologically important cysteine residue.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 7479-7482 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 54 |
| Issue number | 54 |
| DOIs | |
| State | Published - 2018 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 The Royal Society of Chemistry.